Avinger,Inc. (NASDAQ:AVGR) Files An 8-K Other EventsItem 8.01 Other Events
On March19, 2018, Avinger,Inc. entered into a binding memorandum of understanding to settle the securities class actions pending against the Company and several of its officers and directors. The settlement is subject to final documentation, notice to class members, and approval of the court. A copy of the press release is furnished as Exhibit99.1 to this Form8-K.
Item 9.01. Financial Statements and Exhibits.
(d)Exhibits
Avinger Inc ExhibitEX-99.1 2 a18-8761_1ex99d1.htm EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Avinger Enters into Settlement Agreement for all Outstanding Securities Class Action Litigation Redwood City,…To view the full exhibit click here
About Avinger,Inc. (NASDAQ:AVGR)
Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Company focuses on introducing products based on its lumivascular platform, which is an intravascular image-guided system. The Company manufactures and sells a suite of products in the United States and certain European markets. The Company’s products include Lightbox imaging console, as well as its Wildcat, Kittycat and the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO). The lumivascular platform offers real-time visualization of the inside of the artery during PAD treatment. The lumivascular platform consists of a capital component Lightbox and a range of disposable catheter products, including Ocelot, Ocelot PIXL, Ocelot MVRX and Pantheris.
